Cancer Immunotherapy with Device
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
32
NCT04739618
Metastatic Solid Cancer Clinical Trial
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 4, 2021
Completion: Dec 31, 2024
Loading map...